EUROPEAN RENAL ASSOCIATION - EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION
Services
How to use the platform
Build a poster
MANAGE ORDERS
FAQs
Contact
HOMEPAGE
Virtual Poster Gallery
PrintingOnline for Collection on-site
Accredited Training
DOI - Digital Object Identifier
What is PosterSessionOnline?
How to send your poster
How to visit the Virtual Poster Gallery
How to build a poster
How to reduce a poster to less than 2 Mb
PosterSessionOnline Image Editor
How to build a poster with our templates
How to work with a template
Templates and instructions
Discussion forum -
49th ERA-EDTA Congress
Topic -
Mineral and bone disease - CKD 5D
If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
Poster:
581
Visits:
693
Title:
EFFICACY, TOLERABILITY, SAFETY PROFILE AND SATISFACTION DEGREE WITH CALCIUM ACETATE AND MAGNESIUM CARBONATE TREATMENT IN HEMODIALYSIS
Authors:
VICENT ESTEVE SIMÓ ,
Centre:
cONSORCI SANITARI TERRASSA (CST)
You must be registered to reply or comment.
EFFICACY, TOLERABILITY, SAFETY PROFILE AND SATISFACTION DEGREE WITH CALCIUM ACETATE AND MAGNESIUM CARBONATE TREATMENT IN HEMODIALYSIS
VICENT ESTEVE SIMÓ
Thread initiator
Subspeciality
Reg:
4/24/2012 2:21:00 PM
Comment# 1
I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.
Comment added on 4/24/2012 2:21:00 PM
You must be registered to reply or comment.
Most viewed poster for this congress
Poster:
424
Visits:
2636
Title:
Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Glomerulonephritides: an Immunohystochemical expression analysis
Authors:
Giuseppe Coppolino ,
Centre:
Chair of Nephrology, University Magna Graecia of Catanzaro, Catanzaro, Italy
Poster most viewed in this topic
Poster:
558
Visits:
1052
Title:
CINACALCET VS. PARICALCITOL IN HEMODIALYSIS PATIENTS
Authors:
NICKOS KAPERONIS ,
Centre:
RED CROSS HOSPITAL, ATHENS
View Poster Gallery
Back to congress home
Other Congresses
About us
|
Terms and Conditions
|
Special Access